Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
01/09/2026 08:30
BRIEF-Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners Sept 1 (Reuters) - Sakar Healthcare Ltd SAKA.NS:
SAKAR HEALTHCARE - GETS 14 ONCOLOGY PRODUCT NEW APPROVALS IN EU, UK, CANADA WITH 7 BUSINESS PARTNERS
Source text: [ID:]
Further company coverage: SAKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar